Related Experiment Videos
[Defects in the prostaglandin system. VI. Acquired plasma factor defect]
H Sinzinger1, P Fitscha, F Rauscha
1Atheroskleroseforschungsgruppe (ASF), Wien.
Wiener Klinische Wochenschrift
|November 4, 1988
Summary
A patient experienced myocardial infarction and initially had normal plasma factor activity. Later, this activity was lost, indicating an acquired deficiency potentially linked to cardiovascular health.
Area of Science:
- Cardiology
- Biochemistry
Background:
- A 44-year-old male presented with myocardial infarction in 1984.
- Initial plasma examinations showed normal factor activity.
Observation:
- Plasma factor activity remained present at a 1-year follow-up.
- By February 1987, the patient's plasma lost the ability to enhance prostacyclin (PGI2) synthesis in vitro.
- This acquired absence of plasma factor activity persisted over subsequent examinations.
Findings:
- The patient developed an acquired deficiency in plasma factor activity.
- The cause of this deficiency remains unknown.
- No clinical deterioration was observed in the patient.
Implications:
- This case highlights a potential link between acquired plasma factor deficiency and cardiovascular events.
- Further research is needed to elucidate the cause and clinical significance of this deficiency.
- Understanding this factor's role may offer new insights into myocardial infarction pathogenesis.